COVID (SARS-COV-2) VACCINE

Course overview

COVID-19 VACCINES (TOZINAMERAN (BNT162B2) AND MRNA-1273 SARS-COV-2) RECEIVED FDA EMERGENCY USE AUTHORIZED (EUA) TO PREVENT COVID-19 CAUSED BY THE SARS-COV-2 VIRUS. THIS ACTIVITY REVIEWS THE INDICATIONS, ADMINISTRATION, AND CONTRAINDICATIONS FOR COVID-19 VACCINES: TOZINAMERAN (BNT162B2) AND MRNA-1273 SARS-COV-2. THIS ACTIVITY WILL ALSO HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY ELEMENTS OF THE COVID-19 VACCINES IN THE CLINICAL SETTING FOR THE INTERPROFESSIONAL TEAM MEMBERS WHEN VACCINATING INDIVIDUALS TO PREVENT COVID-19 AND ITS RELATED CONDITIONS SEQUELAE.